Neurol. praxi. 2014;15(4):197-201

Multiple sclerosis and pregnancy

MUDr. Olga Zapletalová
Centrum pro roztroušenou sklerózu, Neurologická klinika FN Ostrava, Lékařská fakulta OU, Ostrava

Multiple sclerosis is an autoimmune inflammatory and neurodegenerative disease affecting young women of childbearing age. Owing to the knowledges and modern therapeutic approaches the illness can be really stable and women can carry out their biological role and have children. Maternal immune system undergoes profound transformations at the very beginning of pregnancy. The major changes are directed to protect the fetus from a detrimental immune response and the growing level of pregnancy hormones affects the mother´s immune reactions. According to the results of the clinical trials and long-term clinical experience the pregnancy has positive effect on the course of multiple sclerosis and the long term prognosis of the disease is not worsened due to pregnancy mainly in patients with relapsing type. Multiple sclerosis has little or no direct effect on fertility, mode of delivery and on neonatal health.

Keywords: multiple sclerosis, pregnancy, delivery, disease modulating drugs, breastfeeding, pregnancy hormones, fertility

Published: September 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zapletalová O. Multiple sclerosis and pregnancy. Neurol. praxi. 2014;15(4):197-201.
Download citation

References

  1. Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M. MS study Group of the Italián Neurological Society. Pregnancy and fetal outcomes after interferon-? exposure in multiple sclerosis. Neurology 2010; 75(20): 1794-1802. Go to original source... Go to PubMed...
  2. Airas L, Kaaja R. Pregnancy and multiple sclerosis, Obstetrics Medicine 2012; 5: 94-97, DOI: 10.1258. Go to original source... Go to PubMed...
  3. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy - related relapses in multiple sclerosis. N Engl J Med. 1998; 339: 285-291. Go to original source... Go to PubMed...
  4. Coyle PK. Multiple sclerosis in pregnancy. Continuum (Minneap Minn) 2014; 20(1): 42-59. Go to original source... Go to PubMed...
  5. Fischerová-Duckelmannová A, Bayerová A. Žena lékařkou: lékařská kniha, věnovaná péči o zdraví a léčbě nemocí se zvláštním ohledem na ženské a dětské nemoci, pomoc ku porodu a ošetřování dítek. Brno: Brněnská nakladatelská; společnost, 1923: 613.
  6. Hanulíková P, Binder T. Těhotenství a roztroušená skleróza. Postgraduální medicína 2012; 14(9).
  7. Hellwig K, Rockhoff M, Gold R, Langer-Gould A. Exclusive breast-feeding is beneficial in postpartum relapse rate reduction: A prospective study of 72 MS patiens. Mult Scler 2011; 17: S2777-S505.
  8. Hellwig K, Haghikia A, Gold R. Pregnancy and Natalizumab: results of anobservational study in 35 accidental pregnancies during natalizumab treatmnent. Mult Scler 2011; 17: 95. Go to original source... Go to PubMed...
  9. Havrdová E. Roztroušená skleróza Praha: Mladá fronta, 2013; 485 s.
  10. Koliba P, Zapletalová O, Petzel M. Vliv gravidity na průběh roztroušené mozkomíšní sklerózy. Česk Slov Neurol N 2006; 69/102(2): 125-129.
  11. Langer-Gould A, Juany SM, Gusta R, Leimpeter AD, Greenwood E, Albers KB, Van Den Eeden SK, Nelson LM. Exclusive breast-feeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 2009; 66: 958-963. Go to original source... Go to PubMed...
  12. Lu E, Wang BW, Guimond C, Synnes A, Sadovnick AD, Dahlgren L, Traboulsee A, Tremlett H. Safety of disease-modyfying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance. Expert Rev. Neurother. 2013; 13(3): 251-261. Go to original source... Go to PubMed...
  13. Meluzínová E. Těhotenství a roztroušená skleróza. Neurol. praxi 2010; 11(5): 297-299.
  14. Patas K, Engler JB, Friese MA, Gold SM. Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for diestase aktivity. Journal of reproduktive imunology 97. 2013; 140-146. Go to original source... Go to PubMed...
  15. Roth DE. Vitamin D supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials. J. Perinatol 2011; 31(7): 449-459. Go to original source... Go to PubMed...
  16. Salminen HJ, Legett H, Boggild M. Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J. Neurol. 2010; 257: 2020-2023. Go to original source... Go to PubMed...
  17. Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S Jr, Lepore V, Grand'maison F, Duquette P, Izquierdo G, Grammond P, Amato MP, Bergamaschi R, Giuliani G, Boz C, Hupperts R, Van Pesch V, Lechner-Scott J, Cristiano E, Fiol M, Oreja-Guevara C, Saladino ML, Verheul F, Slee M, Paolicelli D, Tortorella C, D'Onghia M, Iaffaldano P, Direnzo V, Butzkueven H. MS Base Study group and the New Zealand MS Prevalence Study group. Geografical variations on sex ratio trends overtime in multiple sclerosuis. PloS One 2012; 7(10): e48078. Go to original source... Go to PubMed...
  18. Vachová M. Epidemie roztroušené sklerózy ve světě? Česk Slov Neurol N 2012; 75/108(6): 701-706.
  19. Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P, Confavreux C. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post - partum relapse. Brain 2004; 127: 1353-1360. Go to original source... Go to PubMed...
  20. Vukusic S, Confavreux C. Pregnancy and multiple sclerosis. The Children of PRIMS. Clin Neurol. Neurosurg. 2006; 108: 226-270. Go to original source... Go to PubMed...
  21. Weber-Schoendorfer C, Schaefer C. Multiple sclerosis, immunomodulators and pregnancy outcome: a prospective observational study. Mult Scler 2009; 15: 1037-1042. Go to original source... Go to PubMed...
  22. www.statistikaamy.cz 2012.
  23. Zapletalová O. Atrofie mozku u roztroušené sklerózy a možnosti medikamentózního ovlivnění. Remedia 2013; 23: 334-341.
  24. Zenclussen AC. Adaptive immune responses during pregnancy. Am J Reprod Immmunol 2013; 69(4): 291-303. Go to original source... Go to PubMed...
  25. Zhornitsky S, Yong VW, Weiss S, etz LM. Prolactin in multiple sclerosis. Multiple Sclerosis Journal 2012; 19(1): 15-23. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.